185 related articles for article (PubMed ID: 37467060)
1. Exploring the landscape of synthetic IL-6-type cytokines.
Scheller J; Ettich J; Wittich C; Pudewell S; Floss DM; Rafii P
FEBS J; 2024 May; 291(10):2030-2050. PubMed ID: 37467060
[TBL] [Abstract][Full Text] [Related]
2. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.
Giraldez MD; Carneros D; Garbers C; Rose-John S; Bustos M
Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):787-803. PubMed ID: 34211157
[TBL] [Abstract][Full Text] [Related]
3. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
4. Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative disorders.
Sims NA
Cytokine Growth Factor Rev; 2015 Oct; 26(5):517-22. PubMed ID: 26198769
[TBL] [Abstract][Full Text] [Related]
5. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.
Kumar NP; Sridhar R; Banurekha VV; Jawahar MS; Fay MP; Nutman TB; Babu S
Ann Am Thorac Soc; 2013 Oct; 10(5):441-9. PubMed ID: 23987505
[TBL] [Abstract][Full Text] [Related]
7. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
8. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
9. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers.
Rose-John S; Schooltink H
Recent Results Cancer Res; 2007; 174():57-66. PubMed ID: 17302185
[TBL] [Abstract][Full Text] [Related]
10. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.
Murakami M; Kamimura D; Hirano T
Immunity; 2019 Apr; 50(4):812-831. PubMed ID: 30995501
[TBL] [Abstract][Full Text] [Related]
12. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting].
Drutskaya MS; Nosenko MA; Atretkhany KS; Efimov GA; Nedospasov SA
Mol Biol (Mosk); 2015; 49(6):937-43. PubMed ID: 26710772
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA
Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608
[TBL] [Abstract][Full Text] [Related]
14. Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.
Roth M; Block LH
Thorax; 2000 Aug; 55(8):678-84. PubMed ID: 10899245
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation.
Gupta D; Orehek S; Turunen J; O'Donovan L; Gait MJ; El-Andaloussi S; Wood MJA
Cells; 2023 Sep; 12(18):. PubMed ID: 37759507
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.
Banerjee M; Saxena M
Clin Chim Acta; 2012 Aug; 413(15-16):1163-70. PubMed ID: 22521751
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists.
Jazayeri JA; Carroll GJ; Vernallis AB
Int Immunopharmacol; 2010 Jan; 10(1):1-8. PubMed ID: 19804846
[TBL] [Abstract][Full Text] [Related]
18. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.
Metcalfe RD; Putoczki TL; Griffin MDW
Front Immunol; 2020; 11():1424. PubMed ID: 32765502
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane.
Schroers A; Hecht O; Kallen KJ; Pachta M; Rose-John S; Grötzinger J
Protein Sci; 2005 Mar; 14(3):783-90. PubMed ID: 15722452
[TBL] [Abstract][Full Text] [Related]
20. Treatment of type 2 diabetes with the designer cytokine IC7Fc.
Findeisen M; Allen TL; Henstridge DC; Kammoun H; Brandon AE; Baggio LL; Watt KI; Pal M; Cron L; Estevez E; Yang C; Kowalski GM; O'Reilly L; Egan C; Sun E; Thai LM; Krippner G; Adams TE; Lee RS; Grötzinger J; Garbers C; Risis S; Kraakman MJ; Mellet NA; Sligar J; Kimber ET; Young RL; Cowley MA; Bruce CR; Meikle PJ; Baldock PA; Gregorevic P; Biden TJ; Cooney GJ; Keating DJ; Drucker DJ; Rose-John S; Febbraio MA
Nature; 2019 Oct; 574(7776):63-68. PubMed ID: 31554967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
